Last reviewed · How we verify

Golytely (Sodium Bicarbonate)

Abbott · FDA-approved approved Small molecule Quality 47/100

Golytely works by neutralizing stomach acid and helping to protect the stomach lining.

Golytely, a sodium bicarbonate formulation by Abbott, holds a significant market position as a leading gastrointestinal preparation, though it is not the world's best-selling drug. Its competitive advantage lies in its mechanism of neutralizing stomach acid and protecting the stomach lining, distinguishing it from key competitors like sodium chloride, sodium citrate, and magnesium citrate. A key risk is the lack of clinical trials to support additional indications, which may limit its market expansion. The pipeline outlook remains constrained due to the absence of ongoing clinical trials and the requirement for a PD-L1 companion diagnostic for several potential new indications.

At a glance

Generic nameSodium Bicarbonate
SponsorAbbott
Drug classsodium bicarbonate
ModalitySmall molecule
Therapeutic areaGastroenterology
PhaseFDA-approved
First approval1981

Mechanism of action

The primary mode of action is thought to be through the osmotic effect of polyethylene glycol 3350 which causes water to be retained in the colon and produces watery stool.

Approved indications

Boxed warnings

Common side effects

Serious adverse events

Drug interactions

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: